Top Markets
Coin of the day
Citius Oncology, Inc. Citius Oncology, Inc.

Citius Oncology, Inc.

CTOR
주식 순위 #23802
Citius Oncology, Inc. concentrates on advancing innovative, targeted... Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.
주가
$0.7426
마지막 동기화: 2026-08-21
시가총액
$69.05M
변동 (1일)
-2.17%
변동 (1년)
-57.57%
국가
US
거래 Citius Oncology, Inc. (CTOR)

카테고리

Citius Oncology, Inc. (CTOR)의 주가 이력
최고 종가: $0.77 (2026-08-01 기준)

최저 종가: $11.37 (2024-07-01 기준)
Citius Oncology, Inc.의 주가 이력 (2024 ~ 2026)
연간 주가 성과
연도 성과
2026 (TTM) -4.49%
2025 2.60%
2024 0.00%
유사 기업 또는 경쟁사의 주가
회사 주가 변동률 1년% 국가
$1.26K 76.64%
US
$270.77 51.02%
US
$265.40 26.02%
US
$493.69 44.66%
CH
$152.42 74.45%
US